Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Erin Scott/Pool/Getty Images

Anthony Fauci told PBS NewsHour on Thursday that he expects the U.S. could "be as good [as] back to normal as we possibly can" by the end of 2021 if a coronavirus vaccine becomes widely available.

The big picture: Fauci made clear that this would not mean the virus is eradicated, saying, "We can get it under good enough control that it is so low that it doesn't interfere with the kind of normal life that we want to get the economy back, to get employment back."

  • "I do not think it is going to be 2024. I think it's going to be more like the end of 2021."

The state of play: Several vaccine candidates have entered human trials, though their effectiveness might not be what Americans are used to.

  • Fauci said last week that there are "not great" chances that an eventual vaccine will be 98% effective, arguing instead that the vaccine would likely reduce a person’s risk of infection by 50% or 60%.
  • The FDA says it will only require a 50% effectiveness rate for approval.
  • "You’ve got to think of the vaccine as a tool to be able to get the pandemic to no longer be a pandemic, but to be something that’s well controlled," Fauci added.

Go deeper

Updated Nov 22, 2020 - Health

FDA authorizes emergency use of Regeneron antibody treatment given to Trump

The corporate and research and development headquarters of Regeneron Pharmaceuticals, Inc. in Tarrytown, N.Y. Photo: Lev Radin/Pacific Press/LightRocket via Getty Images


The Food and Drug Administration announced Saturday evening it has granted emergency use authorization for Regeneron Pharmaceuticals' antibody cocktail given to President Trump to treat his COVID-19 infection last month.

Why it matters: Regeneron's two monoclonal antibodies, casirivimab and imdevimab, are for people who tested positive for the coronavirus and "who are at high risk for progressing to severe COVID-19" — including people who are 65 and older, and/or people with certain chronic illnesses, per an FDA statement.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Vaccines: Massachusetts to mandate COVID vaccination for long-term care staff — CVS, Walgreens see uptick of people getting COVID vaccines — WHO calls for moratorium on booster shots through September.
  2. Health: Fauci fears a COVID variant worse than Delta could be coming — America's pandemic pessimism returns — Florida counties hold off on adding more testing despite Delta surge.
  3. Politics: Arkansas governor says he regrets banning mask mandatesBiden tells GOP governors who resist COVID rules to "get out of the way" — Florida school district reverses mask mandate after DeSantis' funding threat.
  4. Business: Biden voices support for private sector vaccine requirements — More corporations are requiring workers to get vaccinated.
  5. World: Israel reinstates restrictions as cases surge— Wuhan to test all residents for COVID-19 amid Delta variant concerns.
  6. Variant tracker: Where different strains are spreading.
Nov 21, 2020 - Health

Some ski resorts resume operations under new COVID-19 guidelines

Photo: George Rose/Getty Images

A collection of resorts across the U.S. are beginning to reopen their mountains to skiers by implementing fresh rules to prevent the coronavirus from spreading this winter season.

Why it matters: The ski industry, as many other service and recreation-based businesses, suffered from shutdowns at the start of the pandemic. Winter sports, such as skiing and snowboarding, involve "an element of risky behavior when it comes to viral infection, such as the closeness of riding lifts and trams," the Wall Street Journal writes.